Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation.
暂无分享,去创建一个
[1] Dung-Tsa Chen,et al. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer , 2013, Cancer Immunology, Immunotherapy.
[2] R. Noelle,et al. Critical Role for All-trans Retinoic Acid for Optimal Effector and Effector Memory CD8 T Cell Differentiation , 2013, The Journal of Immunology.
[3] Yu-Chen Lin,et al. Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer , 2013, Proceedings of the National Academy of Sciences.
[4] D. Speiser,et al. CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses , 2012, Cancer Immunology, Immunotherapy.
[5] A. Ross,et al. All-Trans-Retinoic Acid and the Glycolipid α-Galactosylceramide Combined Reduce Breast Tumor Growth and Lung Metastasis in a 4T1 Murine Breast Tumor Model , 2012, Nutrition and cancer.
[6] T. Mallevaey,et al. Strategy of lipid recognition by invariant natural killer T cells: ‘one for all and all for one’ , 2012, Immunology.
[7] K. Tarte,et al. Characterization of a Transitional Preplasmablast Population in the Process of Human B Cell to Plasma Cell Differentiation , 2011, The Journal of Immunology.
[8] J. Rossjohn,et al. New ways to turn on NKT cells , 2011, The Journal of experimental medicine.
[9] Shweta Jain,et al. CD40 Signaling Synergizes with TLR-2 in the BCR Independent Activation of Resting B Cells , 2011, PloS one.
[10] S. Nutt,et al. Germinal center B and follicular helper T cells: siblings, cousins or just good friends? , 2011, Nature Immunology.
[11] Irene Puga,et al. Innate control of B cell responses. , 2011, Trends in immunology.
[12] A. Ross,et al. Retinoic Acid and α-Galactosylceramide Differentially Regulate B Cell Activation In Vitro and Augment Antibody Production In Vivo , 2011, Clinical and Vaccine Immunology.
[13] R. Rickert,et al. Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation. , 2011, Current opinion in immunology.
[14] Yifan Ma,et al. Vitamin A and retinoic acid in the regulation of B-cell development and antibody production. , 2011, Vitamins and hormones.
[15] T. Tedder,et al. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer , 2010, Annals of the New York Academy of Sciences.
[16] S. Naderi,et al. Regulation of B cell proliferation and differentiation by retinoic acid. , 2009, Seminars in immunology.
[17] J. Mora,et al. Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells. , 2009, Seminars in immunology.
[18] K. Rajewsky,et al. Fas receptor expression in germinal-center B cells is essential for T and B lymphocyte homeostasis. , 2008, Immunity.
[19] M. Huber,et al. Enhanced B‐cell activation mediated by TLR4 and BCR crosstalk , 2008, European journal of immunology.
[20] T. Tedder,et al. Regulatory B cells as inhibitors of immune responses and inflammation , 2008, Immunological reviews.
[21] G. Besra,et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo , 2008, Proceedings of the National Academy of Sciences.
[22] L. Gapin,et al. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. , 2008, Current opinion in immunology.
[23] M. Fujimoto,et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. , 2008, Immunity.
[24] F. Ronchi,et al. Immune regulation by invariant NKT cells in autoimmunity. , 2008, Frontiers in bioscience : a journal and virtual library.
[25] G. A. Lang,et al. Glycolipid‐activated NKT cells support the induction of persistent plasma cell responses and antibody titers , 2008, European journal of immunology.
[26] G. A. Lang,et al. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. , 2008, Blood.
[27] James M. Wettenhall,et al. Identification of Pax5 Target Genes in Early B Cell Differentiation1 , 2008, The Journal of Immunology.
[28] T. Yamazaki,et al. Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. , 2008, Blood.
[29] A. Baxter,et al. Interactions between B-Lymphocytes and Type 1 NKT Cells in Autoimmune Diabetes , 2008, Journal of immunotoxicology.
[30] S. Nutt,et al. The regulation of the B‐cell gene expression programme by Pax5 , 2008, Immunology and cell biology.
[31] C. Webb,et al. Retinoids Accelerate B Lineage Lymphoid Differentiation1 , 2008, The Journal of Immunology.
[32] F. Alt,et al. S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase. , 2007, Immunity.
[33] A. Ross,et al. Retinoic Acid Regulates CD1d Gene Expression at the Transcriptional Level in Human and Rodent Monocytic Cells , 2007, Experimental biology and medicine.
[34] S. Pillai,et al. Naive recirculating B cells mature simultaneously in the spleen and bone marrow. , 2007, Blood.
[35] Roger Sciammas,et al. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. , 2006, Immunity.
[36] K. Morikawa,et al. All-trans-retinoic acid accelerates the differentiation of human B lymphocytes maturing into plasma cells. , 2005, International immunopharmacology.
[37] A. Ross,et al. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[38] N. Engedal,et al. Survival of activated human T lymphocytes is promoted by retinoic acid via induction of IL-2. , 2004, International immunology.
[39] K. Calame,et al. Transcription factors controlling the beginning and end of B-cell differentiation. , 2003, Current opinion in genetics & development.
[40] H. Kagechika,et al. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. , 2003, International immunology.
[41] Kuo-I Lin,et al. Blimp-1-Dependent Repression of Pax-5 Is Required for Differentiation of B Cells to Immunoglobulin M-Secreting Plasma Cells , 2002, Molecular and Cellular Biology.
[42] M. Schebesta,et al. Transcriptional control of B-cell development. , 2002, Current opinion in immunology.
[43] V. Singh,et al. Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma* , 2002, The Journal of Biological Chemistry.
[44] A. Ross,et al. All‐trans‐retinoic acid and polyriboinosinic : polyribocytidylic acid in combination potentiate specific antibody production and cell‐mediated immunity , 2001, Immunology.
[45] G. Kelsoe,et al. Spontaneous formation of germinal centers in autoimmune mice , 2001, Journal of leukocyte biology.
[46] Abraham Kupfer,et al. TCR-Induced Transmembrane Signaling by Peptide/MHC Class II Via Associated Ig-α/β Dimers , 2001 .
[47] J. Kappler,et al. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers. , 2001, Science.
[48] S. Gerondakis,et al. Rel Induces Interferon Regulatory Factor 4 (IRF-4) Expression in Lymphocytes , 2000, The Journal of experimental medicine.
[49] J. Delabie,et al. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. , 1999, Blood.
[50] M. Inaoki,et al. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.
[51] T. Mak,et al. Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function , 1997, Science.
[52] S. Sato,et al. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.